Phosphoinositide 3-kinase gamma/delta inhibition limits infarct size after myocardial ischemia/reperfusion injury. - Wikidata - awgldk - TriplyDB

Phosphoinositide 3-kinase gamma/delta inhibition limits infarct size after myocardial ischemia/reperfusion injury.

Phosphoinositide 3-kinase gamma/delta inhibition limits infarct size after myocardial ischemia/reperfusion injury.

http://www.wikidata.org/entity/Q35225599

about

Myocardial reperfusion injury: looking beyond primary PCI PI3Kγ in hypertension: a novel therapeutic target controlling vascular myogenic tone and target organ damage A role for a CXCR2/phosphatidylinositol 3-kinase gamma signaling axis in acute and chronic vascular permeability.Myocardial survival signaling in response to stem cell transplantation.Genetic or pharmaceutical blockade of phosphoinositide 3-kinase p110δ prevents chronic rejection of heart allografts PI3Kδ inhibition reduces TNF secretion and neuroinflammation in a mouse cerebral stroke model.Phosphatidylinositol-3-kinase gamma plays a central role in blood-brain barrier dysfunction in acute experimental stroke.Receptor tyrosine kinases and TLR/IL1Rs unexpectedly activate myeloid cell PI3kγ, a single convergent point promoting tumor inflammation and progression.Distinctive ERK and p38 signaling in remote and infarcted myocardium during post-MI remodeling in the mouse.Redox-sensitive oxidation and phosphorylation of PTEN contribute to enhanced activation of PI3K/Akt signaling in rostral ventrolateral medulla and neurogenic hypertension in spontaneously hypertensive rats Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor Myocardial ischemia-reperfusion injury: a neglected therapeutic target.Proangiogenic growth factors potentiate in situ angiogenesis and enhance antifungal drug activity in murine invasive aspergillosis Aloperine protects mice against ischemia reperfusion (IR)-induced renal injury by regulating PI3K/AKT/mTOR signaling and AP-1 activity.Role of phosphoinositide 3-kinase signaling in autoimmunity.Pharmacologic therapeutics for cardiac reperfusion injury.Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology.The magnitude and temporal dependence of apoptosis early after myocardial ischemia with or without reperfusion.H-ras regulates angiogenesis and vascular permeability by activation of distinct downstream effectors.Phosphoinositide 3-kinases and their role in inflammation: potential clinical targets in atherosclerosis?Novel inhibitors of the PI3K family.PI3K inhibitors in cardiovascular disease.Therapeutic applications of PI3K inhibitors in cardiovascular diseases.Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target.Role of phosphoinositide 3-kinase in the pathogenesis of acute pancreatitis.PI3K inhibitors in inflammation, autoimmunity and cancer.Inhibition of p110δ PI3K prevents inflammatory response and restenosis after artery injury.Involvement of phosphoinositide 3-kinase gamma in angiogenesis and healing of experimental myocardial infarction in mice.Phosphoinositide 3-kinase gamma gene knockout impairs postischemic neovascularization and endothelial progenitor cell functions.Pharmacological targeting of phosphoinositide lipid kinases and phosphatases in the immune system: success, disappointment, and new opportunities.A microwave assisted intramolecular-furan-Diels-Alder approach to 4-substituted indoles.Chronic treatment with LY294002, an inhibitor of phosphatidylinositol 3-kinase, attenuates ischemia/reperfusion-induced cardiac dysfunction in normotensive and hypertensive diabetic animals.PI3Kγ inhibition reduces blood pressure by a vasorelaxant Akt/L-type calcium channel mechanism

P2860

Q26991482-21272330-2A90-40B7-BC7A-A27BCBA11184 Q27026365-7E6D2B3F-6477-4C8B-8EC8-039536CE893A Q28566820-43B0877A-8D69-45F9-AE01-1A72E0667EDD Q33635730-3615DC40-DB06-4367-8002-B6B71FA4CF1D Q34221228-EFE5BB46-0A63-44A4-ACC4-41D713F3C50D Q34409918-A2CA8CCF-92C9-4BF6-B13F-76B6AC13D07A Q35086740-B1C3AB58-5092-45C1-B933-F81F98554A66 Q35129307-2FC6F99F-4229-4C4C-A7C1-68B7DC13922E Q36096234-78383ED6-DBFF-4F2B-999F-6F872D78A31A Q36415676-3FD4E968-6336-497B-8EBE-74657DE4EA0C Q36478465-F81FB17B-EEA7-4AF1-9E50-6F171F07D378 Q36497176-13A1DB71-3294-443E-89A2-8DF51D6CF0A6 Q36641630-75216CAD-045F-4B9B-B027-7D0919F2A717 Q36758002-30D9441B-CBB8-4D20-99DB-D38BBD72C89F Q36922987-D688BD1E-AA83-468B-8811-9C7068F1921A Q36944008-E29254CF-0776-473D-981B-20518A4DD181 Q37090971-6CCF818A-FE1D-43F4-9019-B44D3F22E1C0 Q37139791-BBCB4D17-6ED8-44A9-801D-828A6505DBC0 Q37346629-9004F33E-C96A-4B7F-AC96-C128D685F77A Q37461480-84FE0543-A287-4D66-A446-0743E4312F58 Q37546115-AE698F65-E2A3-4C99-A4BA-BB59F13B036F Q37772192-2309A841-AA6D-447B-AB76-5876C8394FFC Q38089742-D1CF7018-43FD-4D3C-9274-398EAD5E9A26 Q38134311-3066020F-A661-4D46-AD61-9CFC60347295 Q38266869-ADF19DFA-9B33-4935-9615-B082B8220AFC Q38532898-DAF01261-8C09-4D22-9B60-73748C2EACE7 Q38603120-DBC0931B-97B1-4541-AECF-D7A64F216EF5 Q39441600-31CD581E-73B4-4BB0-A1C3-AE997D5CD094 Q41838531-99640102-A676-4DE0-9B77-4F798DB63B71 Q42178173-65951417-22C0-42B6-BF16-B07B0E307254 Q42543241-A1B2166B-327A-4D54-BD93-FD966714A401 Q54473465-9E12C538-DF90-4923-8EA2-1A1803FAFE0B Q57005928-4F4DC3A2-ABA7-4D24-A286-743DAB86833E

P2860

Phosphoinositide 3-kinase gamma/delta inhibition limits infarct size after myocardial ischemia/reperfusion injury.

http://www.wikidata.org/entity/Q35225599

description

2006 nî lūn-bûn

@nan

2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Phosphoinositide 3-kinase gamm ...... l ischemia/reperfusion injury.

@ast

Phosphoinositide 3-kinase gamm ...... l ischemia/reperfusion injury.

@en

type

label

Phosphoinositide 3-kinase gamm ...... l ischemia/reperfusion injury.

@ast

Phosphoinositide 3-kinase gamm ...... l ischemia/reperfusion injury.

@en

prefLabel

Phosphoinositide 3-kinase gamm ...... l ischemia/reperfusion injury.

@ast

Phosphoinositide 3-kinase gamm ...... l ischemia/reperfusion injury.

@en

P1433

Q35225599-D5721992-BA80-4635-A2D3-5ECCEF7539CC

P1476

Q35225599-3BDEE7C3-2714-40AA-8548-3CD2B433E2BE

P2093

Q35225599-21ACDC5A-25BB-480D-9AD0-2C32E7280EA3

Q35225599-26C28EBC-9465-4779-87AE-E3D1CFDDC806

Q35225599-27AB15F7-18A1-46A5-871C-8D19E184C33D

Q35225599-5E55D26F-CB3A-4646-9F60-2A35D1C9157A

Q35225599-624D0C6F-ADF8-4E1B-AA80-44D357C2EB0E

Q35225599-63642226-8CB7-4435-BE5F-1DC594DF83B8

Q35225599-8B94E395-3A4F-4A51-A719-D9C38DCA2BFB

Q35225599-A9B12B86-705F-4CC7-BCA8-509BD6DC1F2E

Q35225599-CFE33CEE-D6D9-4F56-BF19-DB502DEAA4DC

Q35225599-F772898F-C4EE-403F-83F5-A56384AC1AD8

P2860

Q35225599-07FE04F1-49BC-46DE-AF5E-E2AC3EF1CC09

Q35225599-0C01CADE-6EE2-4E84-9D9F-71A7C03EEB63

Q35225599-0F48251D-0C33-4203-84E5-90D4AD9B2130

Q35225599-1526D16A-C632-4AC8-B8E5-9BC43ECF5D48

Q35225599-1DA89966-34E5-4566-8DAA-4B65CD8255FA

Q35225599-234A4064-E8A4-4F91-9C1F-712FA3800C62

Q35225599-2A290CC6-A45C-449D-A121-895C9B210D49

Q35225599-3168B8A2-9497-424A-AC51-3B4BF665B14F

Q35225599-397CFB91-8F66-44E7-83AF-76BAB9DC1D67

Q35225599-3B8BDC58-E0DF-4686-B5B9-0FEA61B14832

P304

Q35225599-6646307F-46A6-47D2-B830-0F5BF16A44A6

P31

Q35225599-6F7606C9-0996-4CA9-A08A-AABF31CB75F4

P356

Q35225599-D06338DA-3514-4628-AE72-639F24B0879E

P407

Q35225599-4F66A2F3-9EB5-4095-B7C7-7A9334217A36

P433

Q35225599-DC11BBAB-9675-423B-9CE8-FBB1E63BC221

P478

Q35225599-57F5AE20-044F-42E1-835C-78977E5ED88C

P577

Q35225599-19D50104-862C-4EFB-B339-8648B3117396

P5875

Q35225599-C092EF89-FCBE-4383-8B6E-10AC662AFCF3

P698

Q35225599-DC8805E4-6351-4E3A-B453-E7A012BB338F

P932

Q35225599-62CF69A8-D06D-4515-B7FF-094A51F8544E

P356

PNAS.0606956103

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Phosphoinositide 3-kinase gamm ...... l ischemia/reperfusion injury.

@en

P2093

Anthony Demaria

http://www.w3.org/2001/XMLSchema#string

David Cheresh

http://www.w3.org/2001/XMLSchema#string

Elena Dneprovskaia

http://www.w3.org/2001/XMLSchema#string

Glenn Noronha

http://www.w3.org/2001/XMLSchema#string

John Doukas

http://www.w3.org/2001/XMLSchema#string

John Hood

http://www.w3.org/2001/XMLSchema#string

Richard Fine

http://www.w3.org/2001/XMLSchema#string

Richard Soll

http://www.w3.org/2001/XMLSchema#string

Sara Weis

http://www.w3.org/2001/XMLSchema#string

Wolfgang Wrasidlo

http://www.w3.org/2001/XMLSchema#string

P2860

Ischemic preconditioning activates phosphatidylinositol-3-kinase upstream of protein kinase C

Essential role for the p110delta phosphoinositide 3-kinase in the allergic response

Extraction of well-fitting substructures: root-mean-square deviation and the difference distance matrix.

Neutrophils lacking phosphoinositide 3-kinase gamma show loss of directionality during N-formyl-Met-Leu-Phe-induced chemotaxis

Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation.

PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury

Platelet-activating factor and related lipid mediators.

Role of platelet-activating factor in cardiovascular pathophysiology.

New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway.

The inflammatory response in myocardial infarction.

P304

19866-19871

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0606956103

http://www.w3.org/2001/XMLSchema#string

P407

P433

52

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P577

2006-12-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6628515

http://www.w3.org/2001/XMLSchema#string

P698

17172449

http://www.w3.org/2001/XMLSchema#string

P932

1702529

http://www.w3.org/2001/XMLSchema#string